In recent years, the term mental health has become ubiquitous in corporate conversations. However, not every psychological support solution offered in the workplace truly works. Many generic mental health programmes, although well‑intentioned, lack a solid scientific basis and fail to achieve a measurable reduction of anxiety and depression among employees.
In this scenario, science makes all the difference. Without rigorous research, without validated metrics and without clinical professionals involved in the design of each intervention, the results are nothing more than perceptions.
And this is where ifeel redefines the standard of psychological care at a corporate level. Its clinically validated therapy model, developed by its Research and Clinical department, demonstrates with data that mental wellbeing can be measured, improved and, above all, translated into tangible organisational and financial impact.
The science behind ifeel is what separates good intentions from real results. Based on thousands of analysed sessions and internationally accepted psychometric scales (such as GAD, PHQ, WSAS and SOFAS), this methodology demonstrates that when therapeutic intervention is guided by evidence, employees recover more quickly, companies save costs and workplace cultures are transformed.
Precisely to demonstrate the impact of this approach, the Research and Clinical Department has produced ifeel’s clinical report “Reduction of Anxiety and Depression Symptoms”, a scientific study that exhaustively analyses the clinical results obtained by thousands of employees across different sectors and geographies.
Within just six to twelve weeks, participants showed measurable improvements: a significant reduction of anxiety and depression symptoms, increased functionality, and a high return on business investment.
Download the complete clinical report here and discover how science is redefining corporate mental health
An intervention backed by science: Discover ifeel’s clinical report results
Digital mental health solutions have emerged as an effective, scalable, and accessible method for achieving a proven reduction of anxiety and depression. Research from both clinical trials and real‑world studies confirms that digital therapy, particularly when grounded in cognitive‑behavioural approaches (CBT), effectively decreases symptoms on standardised scales such as the PHQ‑9 (depression) and GAD‑7 (anxiety).
In the workplace, this impact is even more powerful. Digital solutions eliminate barriers such as stigma, time constraints, and distance, allowing employees to access consistent support and sustain long‑term improvement.
ifeel’s solution integrates video therapy, continuous clinical monitoring, psychoeducational content, and AI‑based risk management to ensure interventions remain adaptive and data‑driven. This ongoing monitoring is key to maintaining a consistent reduction of anxiety and depression symptoms across the workforce.
What did the study involve?
The “Reduction of Anxiety and Depression Symptoms” report analysed the evolution of emotional well‑being in 6,212 employees across 90+ countries, using real, anonymised data from ifeel’s solution. The interventions combined:
- Therapy guided by clinical professionals (via video call or chat),
- Digital psychoeducation tools
- Personalised therapeutic exercises
- Automated monitoring through clinical risk algorithms.
All participants completed at least one anxiety assessment (GAD-7) and one depression assessment (PHQ-9) within an observation period of 6 to 12 weeks, together with recording their level of functioning according to the SOFAS scale (Social and Occupational Functioning Assessment Scale).
How were the data measured and analysed?
The scales employed were as follows:
- PHQ-9: Assesses the severity of depressive symptoms over the past two weeks.
- GAD-7: Measures the intensity of generalised anxiety symptoms.
- SOFAS: Analyses the degree of social and occupational functioning of the individual.
Assessments were conducted at the start of treatment and monthly to monitor each participant’s clinical progress. The data were analysed using linear mixed models (LMMs), an advanced statistical technique that enables evaluation of individual user progress, even when measurement intervals vary.
This approach made it possible to identify consistent trajectories of symptom reduction and relate them to variables such as total time in therapy, type of intervention, level of risk, and functional improvement. In addition, demographic factors (age, gender, and country) were considered to ensure global validity of the results, and data processing and analysis were conducted in accordance with the highest ethical and regulatory privacy standards (GDPR).
Key results: Quantifying the reduction of anxiety and depression
ifeel’s Research and Clinical Department demonstrated through this study how a therapeutic model that combines clinical psychology, data science and artificial intelligence is capable of precisely measuring the emotional and functional recovery of employees, translating individual improvements into organisational and financial impact.
The results of ifeel’s clinical report: “Reduction of Anxiety and Depression Symptoms”, demonstrate a significant improvement in the emotional well-being and work performance of employees, which we shall summarise in the following table:
| Clinical Indicator | Focus | Average Improvement |
| GAD | Reduction of anxiety symptoms | ↓ 40% |
| PHQ | Reduction of depression symptoms | ↓ 35% |
| WSAS / SOFAS | Improvement in work and social functioning | ↑ 45% |
| User Satisfaction | Post-therapy wellbeing | 82% |
| Business ROI | Average return on investment | 3x |
Results analysis
The results of ifeel’s clinical study reveal a decisive finding: employees’ emotional improvement directly translates into improved work performance.
A 45% increase in daily performance (according to the WSAS and SOFAS scales) indicates that employees not only regain emotional stability but also their concentration, motivation, and confidence in their professional environment.
But the impact is not limited to the individual level. Human Resources departments report a 30% reduction in absenteeism risk among high-risk employees, along with 80% satisfaction among leaders and users of the ifeel platform.
By converting clinical results into economic indicators, ifeel provides companies with an evidence-based perspective that enables them to optimise investment in corporate mental health. The data demonstrate that ifeel’s methodology transforms individual clinical improvement into an organisational competitive advantage: fewer sick leaves, lower turnover, and a notable increase in engagement and productivity.
In short, the study confirms, with quantitative and clinical evidence, that evidence-based digital therapy is an effective, safe and scalable tool for improving mental health in the modern workplace. Its approach combines scientific rigour and technological accessibility, achieving significant reductions in anxiety and depression symptoms and translating them into operational improvements and tangible business value.
Once again, the data support what science had already anticipated: when technology is combined with clinical knowledge, mental health becomes the most profitable investment (in human and economic terms) that a company can make.
The Leadership Lens🔎
ifeel’s innovation goes beyond individual therapy. Through workshops, psychoeducational content and training for leaders, the company helps organisations normalise the conversation about mental health and create emotionally sustainable cultures.
Business leaders who implement ifeel’s methodology not only observe productivity improvements, but a strengthening of organisational trust. By integrating clinical data into their corporate dashboards, HR teams can anticipate risks and adapt their preventive policies with surgical precision.
Explore ifeel’s real impact through our case studies
To gain a deep understanding of how ifeel has transformed mental well-being across different organisations and sectors, we invite you to download our other case studies. These detail real experiences, clinical and financial results, and the personalised strategies we have implemented to maximise impact on teams’ emotional health and productivity.
Discover how leading companies in sectors such as pharmaceuticals, finance, automotive, retail, hospitality, technology, and energy have reduced absenteeism, improved engagement, and fostered a healthy organisational culture thanks to our comprehensive solution.
Do not miss the opportunity to draw inspiration from these examples and take mental well‑being in your organisation to the next level.
Mental health at work: a global business challenge
This study confirms that evidence‑based digital therapy is an effective, safe, and scalable solution for achieving significant reduction of anxiety and depression symptoms in modern workplaces. ifeel’s methodology combines clinical rigour and technological precision, proving that mental health is not just a humanitarian priority but a strategic investment with measurable returns.
When technology meets clinical science, the reduction of anxiety and depression becomes a catalyst for both human and business growth.
Discover the data, methodology and complete results in ifeel’s clinical report. Download the study “Reduction of Anxiety and Depression Symptoms” and transform your organisation’s mental health
